Insights On Outsourced Drug Development

  1. The Complete Guide To Immunohistochemistry 9/24/2024

    Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.

  2. Integrated Strategies for Achieving Regulatory Milestones Faster 10/12/2023

    Learn how an innovative formulation platform reduced development timelines and allowed a sponsor to find the optimal nafamostat formulation without adding unnecessary delays.

  3. The Importance Of Reliable Mixing In ITC Experiments 5/1/2025

    Explore how Isothermal Titration Calorimetry (ITC) precisely analyzes molecular interactions, which provides crucial thermodynamic data to understand physiological processes and develop new therapeutic strategies.

  4. Characterize Lentiviral Vector Quality Attributes Using CE Platform Technology 8/14/2023

    Review this outline of a platform-based approach using capillary electrophoresis (CE) to mitigate the technical difficulties in characterizing LVVs for the assessment of multiple quality attributes.

  5. High-Throughput 90-Minute ELISA 9/17/2024

    Discover how one solution can be utilized to measure Human IgG and human IFN gamma, which are key targets in pharmacokinetic studies and immunotherapeutic drug safety testing, in just 90 minutes.

  6. Using Affinity Chromatography For The Purification Of Lentiviral Particles 3/11/2024

    This new affinity chromatography resin offers an efficient and scalable purification method for lentiviral particles in combination with gentle elution conditions to retain viral infectivity.

  7. In Vitro/In Vivo Permeability: A 4-Cell Line Study 5/21/2025

    Evaluate drug absorption potential across diverse cell barriers and transporter systems using our comparative permeability studies with a variety of cell lines and standard compounds.

  8. Accelerated Peptide Drug Development And Clinical Strategies 10/16/2023

    Review how an integrated platform approach and innovative filtration strategies helped bring a novel therapeutic to Phase 1 clinical trials with reduced time and costs.

  9. Preclinical Evaluation Of New Antifibrotics In NASH-Induced Fibrosis Models 6/10/2025

    Accelerate the development of antifibrotic therapies through our clinically relevant models, deep scientific expertise, and proven preclinical capabilities in this area of unmet medical need.

  10. Genome Editing Using mRNA-Lipid Nanoparticles For CAR T Cell Therapy 11/22/2023

    Gene delivery platforms must support a diversity of genetic engineering strategies for genomic medicine development. Learn how lipid nanoparticles can accelerate development from discovery to scale-up.